Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Interim Management Statement

12 May 2010 11:14

Baronsmead VCT 3 plc Interim Management Statement

For the three month period from 1st January 2010 to 31st March 2010.

Headlines-

* 1.2% increase in Net Asset Value (NAV) per ordinary share * Sale of Active Assistance at 2.8 times cost * We welcome 209 new shareholders and thank the 696 existing shareholders of Baronsmead VCT 3 and Baronsmead VCT 4 who subscribed Β£8m gross proceeds in the recent Joint Offer. Performance SummaryCapital return As at As at Movement 31stMar 31stDec 2010 2009 Total net assets Β£60.7m Β£52.9m Net asset value per share 98.68 97.50 1.2% Share price 88.25 86.25 2.3% Discount to NAV 10.6% 11.5% Total return 3 month (%) 3year (%) Since launch (%) Net asset value(1) 1.2 (6.1) 61.8 Share price(2) 2.3 (3.9) 44.0 FTSE All-share(3) 6.4 (0.7) 31.0 Key:

(1) NAV total return = NAV + reinvested dividends; Source: ISIS EP LLP

(2) Share price total return = Mid to mid share price + reinvested dividends; Source: AIC

(3) FTSE All-share = FTSE All-share Index + reinvested dividends; Source: AIC

These total returns are stated before the inclusion of VCT tax reliefs which are designed to mitigate the higher risks and costs associated with investing in smaller companies and the constraints of the VCT legislation. The tax reliefs given at the time of subscription have been 20%, 40% and later 30%, so any adjusted performance measure including this relief will vary depending on the date of subscription. There is the additional benefit of receiving VCT dividends tax free.

Investment Performance

The NAV per Ordinary share at 31st March 2010 was 98.68p giving a positive total return of 1.2% for the quarter. This compares to the FTSE All-Share Total Return Index increase of 6.4% over the same period. Since launch NAV Total Return is 61.8% which compares with a rise of 31.0% for the FTSE All Share.

Despite the difficult economic outlook the Board and the Manager believe that the portfolio represents sound value at current prices and that the company is well financed to take advantage selectively of further investment opportunities. Unquoted valuations have increased by 4% in the period bringing an uplift to NAV per share.

Top ten Investments Position Position at Percentage at of NAV 31 December Company 31 March20 2009 as at 31 Mar2010 10 1 1 Reed & Mackay 5.5 2 3 Nexus Vehicle Holdings 4.4 3 2 Carnell Contractors 3.3 4 5 Cablecom Networking Holdings 3.1 5 4 Quantix 3.0 6 6 Fisher Outdoor Leisure Holdings 2.9 7 10 CSC (World) 2.7 8 7 Independent Living Services 2.7 9 8 Kafevend Holdings 2.6 10 9 Crew Clothing Company 2.2 Total 32.4 Analysis of Total Assets Percentage of total assets Percentage of total assets 31 March 2010 31 December 2009 AIM, Listed & Collective 22 23 Investments 41 48 Unquoted investments Interest Bearing 29 25 Securities Cash 8 4 Total cash portfolio 37 29 Total Assets 100 100

Analysis of Investment Portfolio by Sector

(excluding cash and interest bearing securities)

Percentage of total Percentage of total investments at investments at 31 March 2010 31 December 2009 Business Services 36 36 Healthcare & 9 13 Education IT & Media 35 31 Financial Services 6 6 Consumer Markets 14 14 Total 100 100 Investment Activity

During the period Active Assistance, an unquoted investment made in March 2008, was realised resulting in a 2.8x return.

Three AIM traded investments totalling Β£0.4m were completed in three existing portfolio companies.

Following the period end an investment of Β£4.4m (across the four Baronsmead generalist VCTs) was completed in Surgi-C, the UK's leading independent distributor of spinal implants.

Investments made Date Cost (Β£'000) Electric Word plc Jan 10 4 Proactis Holdings plc Feb 10 219 Jelf Group plc Feb 10 210 Total Investments 433

In total two AIM investments were realised in full.

Realisations Company Date Cost Proceeds (Β£ Multiple '000) (Β£'000) Character Group plc Feb 10 144 132 0.9 INVU plc Mar 10 35 1 0.0 Total realisations 179 133 0.7Fundraising

The Joint Offer by Baronsmead VCT 3 and Baronsmead VCT 4 raised Β£8m gross proceeds for each VCT. The Offer closed fully subscribed within 8 weeks with approximately 70 per cent being subscribed by existing shareholders from across the five Baronsmead VCTs.

Net Asset Value

The NAV per share at 30 April 2010 was 99.53p representing an increase of 0.9% since the quarter end driven largely by an increase in the value of the AIM portfolio.

Events after the period end

Other than as discussed in this statement the Board is not aware of any significant events or transactions which have occurred between 31 March 2010 and the date of publication of this statement which would have a material impact on the financial position of the Company.

Investment objective

Baronsmead VCT 3 plc is a tax efficient listed company which aims to achieve long-term investment returns for private investors.

Further information

Further information regarding the Company, including net asset values published since the end of the period and quarterly factsheets, can be found at the Company's website www.baronsmeadvct3.co.uk

Contact

For further information please contact:

Michael Probin Investor Relations Manager 020 7506 5600 michael.probin@isisep.com

vendor
Date   Source Headline
4th Jun 20263:15 pmRNSNet Asset Value(s)
3rd Jun 202610:15 amRNSNewsletter for the period June 2025 to March 2026
1st Jun 202611:26 amRNSTotal Voting Rights
18th May 20263:45 pmRNSAdmission of Further Securities to Trading
14th May 20262:15 pmRNSAllotment of Shares and Closure of Offer
11th May 20267:00 amRNSNet Asset Value(s)
5th May 20263:15 pmRNSNet Asset Value(s)
1st May 202611:42 amRNSTotal Voting Rights
8th Apr 202610:15 amRNSAdmission of Further Securities to Trading
1st Apr 202611:48 amRNSTotal Voting Rights
31st Mar 20265:37 pmRNSTransaction in Own Shares
30th Mar 20261:50 pmRNSNet Asset Value(s)
24th Mar 20262:25 pmRNSReplacement - Extension to Application Deadline
24th Mar 202612:20 pmRNSApplication Deadline Extension - Fourth Allotment
20th Mar 20267:00 amRNSResult of AGM
11th Mar 20262:00 pmRNSOver-Allotment Facility and Offer Update
5th Mar 20263:30 pmRNSNet Asset Value(s)
2nd Mar 202611:38 amRNSTotal Voting Rights
26th Feb 202612:15 pmRNSAdmission of Further Securities to Trading
20th Feb 202611:02 amRNSDirector/PDMR Shareholding
19th Feb 20264:30 pmRNSAllotment of Shares and Total Voting Rights
17th Feb 20264:05 pmRNSTransaction in Own Shares
6th Feb 202612:06 pmRNSOffer Update:Close of Early Subscription Incentive
5th Feb 20264:15 pmRNSNet Asset Value(s)
2nd Feb 20264:45 pmRNSNet Asset Value(s)
2nd Feb 202610:39 amRNSTotal Voting Rights
29th Jan 20263:35 pmRNSAdmission of Further Securities to Trading
22nd Jan 20263:40 pmRNSAllotment of Shares and Total Voting Rights
12th Jan 202611:35 amRNSPublication of a Supplementary Prospectus
23rd Dec 20257:00 amRNSAnnual Financial Report
23rd Dec 20257:00 amRNSAnnual Financial Report
4th Dec 20253:45 pmRNSNet Asset Value(s)
1st Dec 202510:44 amRNSTotal Voting Rights
20th Nov 20251:22 pmRNSDirector/PDMR Shareholding
20th Nov 202512:00 pmRNSAllotment of Shares and Total Voting Rights
6th Nov 20254:00 pmRNSNet Asset Value(s)
29th Oct 20259:45 amRNSNet Asset Value(s)
13th Oct 20252:00 pmRNSPublication of a Prospectus/Offer for Subscription
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20255:56 pmRNSTransaction in Own Shares
24th Sep 20258:46 amRNSUpdate on Offer for Subscription
23rd Sep 20252:49 pmRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
11th Sep 20256:06 pmRNSTransaction in Own Shares
11th Sep 20255:09 pmRNSDirector/PDMR Shareholding
4th Sep 20253:15 pmRNSNet Asset Value(s)
4th Sep 20258:15 amRNSIntention to Fundraise
6th Aug 20254:15 pmRNSNet Asset Value(s)
31st Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 202510:00 amRNSNet Asset Value(s)
1st Jul 20255:13 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.